Latest Genentech Stories
The Majority of Surveyed Oncologists Have Already Prescribed Kadcyla, Just Nine Months Post-Launch, According to Findings from Decision Resources Group BURLINGTON, Mass., March 18, 2014 /PRNewswire/
NEW YORK, March 13, 2014 /PRNewswire/ -- Weight Watchers International, Inc.
INCLINE VILLAGE, Nev., March 11, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
- Annual Revenues Increased 18 Percent during 2013 - INCLINE VILLAGE, Nev., March 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
MOUNTAIN VIEW, Calif., Feb. 25, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Robert A.
SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Ambrx Inc. today announced that Sheila Gujrathi, M.D., has joined its board of directors. Dr.
LA JOLLA, Calif., Feb.
ChinaMarketResearchReports.com adds Latest Reports on Atorvastatin and Trastuzumab industry for China to its store. Dallas, TX (PRWEB) February 16, 2014
INCLINE VILLAGE, Nev., Feb. 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F.
- The act of sweetening by admixture of some saccharine substance.